Albert David, Corona Remedies enter into strategic co-marketing agreement
5th Oct 2021

Albert David and Corona Remedies have entered into a strategic co-marketing agreement on October 04, 2021. The company has entered into a strategic Co-Marketing agreement to help take the ‘Placenta Products (Placentrex)’, with another brand name, to a larger and wider group of end beneficiaries. 

Placentrex, the human placental extract product, is an old and well established product of Albert David. It is used by the Gynecologists for PID (Pelvic Inflammatory Disease) and by Surgeons, Physicians and other doctors for difficult to heal wounds.

Albert David (ADL), a prominent drug house, distinguished in the field of manufacturing Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms, Bulk Drugs and Disposable Syringes & Needles has its base in Kolkata, India.